The Global Joint Resurfacing Devices Market is on a steady upward trajectory, with projections indicating the sector will grow from US$ 2.35 billion in 2024 to US$ 3.25 billion by 2031, registering a compound annual growth rate (CAGR) of 4.9% over the forecast period from 2025 to 2031. According to a comprehensive market analysis published by The Insight Partners, several converging forces — demographic shifts, rising disease prevalence, and next-generation surgical technologies — are reshaping demand for these specialized orthopedic devices.

What Are Joint Resurfacing Devices?

Unlike traditional total joint replacement procedures that remove and replace entire joint structures, joint resurfacing devices preserve the patient's natural bone by capping or reshaping the articulating surfaces. This bone-conserving approach reduces the risk of dislocation, lowers the complexity of potential future revision surgeries, and often delivers superior functional outcomes — particularly for younger, physically active patients.

The technology spans multiple joint types, including the knee, hip, shoulder, and ankle. Hip resurfacing, in particular, has emerged as one of the most widely adopted procedures, as it effectively treats conditions such as osteoarthritis and avascular necrosis while helping delay the need for a full hip replacement. Shoulder and ankle resurfacing procedures are also gaining traction, offering patients improved mobility and pain relief while retaining the integrity of surrounding bone and tissue.

Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00041706

Key Market Drivers:

The primary engine behind market growth is the aging global population. As the proportion of elderly individuals rises worldwide, so does the incidence of osteoarthritis and other degenerative joint conditions. However, this demand is not limited to older age groups. Osteoarthritis is increasingly being diagnosed in younger adults, driven by sports injuries, obesity, and high-impact lifestyles. For these patients, joint resurfacing offers a clinically preferred alternative to total joint replacement, preserving mobility and leaving room for future interventions if needed.

Advances in minimally invasive surgical techniques are another significant growth driver. These innovations result in shorter hospital stays, reduced blood loss, less post-operative pain, and faster recovery times. Combined with the integration of artificial intelligence in surgical planning and the adoption of robotic-assisted procedures, the clinical case for joint resurfacing continues to strengthen.

Innovation and Emerging Opportunities:

The market is also being transformed by 3D printing and additive manufacturing, which enable the production of patient-specific implants tailored to individual anatomy. These custom implants improve integration with the patient's bone structure, reduce complication rates, and deliver more consistent outcomes. The combination of resurfacing implants with stem cell and platelet-rich plasma (PRP) therapies is another frontier, offering the potential for cartilage regeneration and extended implant longevity.

A notable recent development includes the full commercial launch of the OvertureTi Knee Resurfacing System by Overture Orthopaedics in July 2025, designed to treat early-stage osteoarthritis and cartilage defects through a procedure known as Focalplasty. Additionally, in December 2024, MatOrtho introduced the ReCerf Hip Resurfacing Arthroplasty — the world's first all-ceramic hip resurfacing system to receive regulatory approval, marking a significant milestone for the industry.

Regional Landscape

North America currently holds the largest market share, supported by a well-established healthcare infrastructure and early adoption of advanced surgical technologies. Asia Pacific is expected to be the fastest-growing region through 2031, driven by a rapidly aging population, increasing rates of sports-related injuries and obesity, and expanding hospital capacity. Europe remains a substantial market, characterized by strong regulatory oversight and growing patient preference for bone-preserving procedures.

Competitive Landscape

The market is dominated by major orthopedic companies including Smith & Nephew, DePuy/Johnson & Johnson, Zimmer Biomet, Stryker, and Exactech, alongside emerging players such as MatOrtho, Medacta International, and Corin Group. Competitive differentiation is increasingly driven by innovation in biomaterials, robotic surgery integration, and the development of patient-specific implant solutions.

As demographic pressures mount and clinical evidence in favor of bone-preserving procedures grows, the joint resurfacing devices market is well-positioned for sustained expansion over the coming decade.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
If you have any queries about this report or if you would like further information, please get in touch with us:
Phone: +1-646-491-9876
Also Available in : Korean|German|Japanese|French|Chinese|Italian|Spanish